Xact Kapitalforvaltning’s Jazz Pharmaceuticals JAZZ Stock Holding History

Xact Kapitalforvaltning’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.39M	Sell	13,981 -1,222	-8%	-$158K	0.03%	416
2019 Q4	$2.27M	Buy	15,203 +281	+2%	+$38.2K	0.04%	385
2019 Q3	$1.91M	Hold	14,922	–	–	0.04%	392
2019 Q2	$2.13M	Buy	14,922 +1,389	+10%	+$187K	0.04%	366
2019 Q1	$1.94M	Buy	13,533 +4,876	+56%	+$636K	0.04%	381
2018 Q4	$1.07M	Sell	8,657 -5,931	-41%	-$880K	0.03%	523
2018 Q3	$2.45M	Sell	14,588 -1,007	-6%	-$173K	0.05%	343
2018 Q2	$2.69M	Buy	15,595 +989	+7%	+$162K	0.06%	330
2018 Q1	$2.21M	Buy	14,606 +374	+3%	+$54.9K	0.05%	378
2017 Q4	$1.92M	Buy	14,232 +719	+5%	+$99.7K	0.05%	404
2017 Q3	$1.98M	Buy	13,513 +212	+2%	+$32.1K	0.06%	368
2017 Q2	$2.07M	Sell	13,301 -335	-2%	-$51.2K	0.06%	351
2017 Q1	$1.98M	Sell	13,636 -44	-0.3%	-$5.73K	0.06%	363
2016 Q4	$1.49M	Buy	13,680 +721	+6%	+$80.3K	0.05%	408
2016 Q3	$1.57M	Buy	+12,959	New	+$1.75M	0.06%	378

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Xact Kapitalforvaltning's JAZZ Position: Q1 2020 in Review

Xact Kapitalforvaltning reduced its Jazz Pharmaceuticals (JAZZ) stake by 8% in Q1 2020, selling an estimated $158K and leaving 13,981 shares worth $1.39M. The position accounts for 0.03% of the portfolio, ranked #416.

Xact Kapitalforvaltning first reported a position in JAZZ in Q3 2016 and has held it in 15 quarters since. The position peaked at $2.69M in Q2 2018. 408 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

Xact Kapitalforvaltning held 13,981 shares of Jazz Pharmaceuticals worth $1.39M as of Q1 2020.
Xact Kapitalforvaltning sold 1,222 Jazz Pharmaceuticals shares in Q1 2020, an estimated $158K.
Jazz Pharmaceuticals made up 0.03% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #416 holding.
Xact Kapitalforvaltning first reported a position in Jazz Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
Xact Kapitalforvaltning's Jazz Pharmaceuticals position peaked at $2.69M in Q2 2018.
408 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.